All In Biotech

Drug Trial Radar · NCT07614984

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-7262 as Monotherapy and When Coadministered With Enlicitide Decanoate in Adults With Elevated Lipoprotein(a)

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 750 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

750

Planned (sponsor's estimate)

Start

Jun 30, 2026

Primary completion

Oct 12, 2027

Study completion Oct 12, 2027

Sponsor

Lead sponsor
Merck Sharp & Dohme LLCMerck & Co. (MRK)
Sponsor type
Industry
First posted
May 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Researchers designed a trial medicine called MK-7262 to lower levels of Lp(a) in the blood. Researchers want to learn about giving MK-7262 with another trial medicine called enlicitide (also known as MK-0616 or enlicitide decanoate). Enlicitide is in a group of medicines that lower the amount of low-density lipoprotein cholesterol (LDL-C). The goals of this trial are to evaluate: * if MK-7262 and enlicitide taken together work better than placebo at lowering Lp(a) and LDL-C levels in the blood * if MK-7262 alone works better than placebo at lowering Lp(a) levels in the blood * the safety and tolerability of taking MK-7262 and enlicitide alone and together

Conditions

  • Lipoprotein(a)

Interventions

  • MK-7262Drug

    Oral Coated Tablet

  • EnlicitideDrug

    Oral Coated Tablet

  • Placebo for MK-7262Drug

    Oral Coated Tablet

  • Placebo for enlicitideDrug

    Oral Coated Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Lipoprotein (a) (Lp(a)) at Week 8Time frame: Baseline and Week 8
  2. Percent Change from Baseline in Low-Density Lipoprotein Cholesterol (LDL-C) at Week 8Time frame: Baseline and Week 8
  3. Number of Participants who Experience One or More Adverse Events (AEs)Time frame: Up to approximately 20 Weeks
  4. Number of Participants Who Discontinue Study Intervention Due to an AETime frame: Up to approximately 12 Weeks

Locations

77 sites in 9 countries. Site status is shown where the registry gives one.

  • Advanced Cardiovascular - Alexander City ( Site 0158)

    Alexander City, Alabama · Recruiting

  • AMR Clinical Mobile ( Site 0149)

    Mobile, Alabama · Recruiting

  • National Heart Institute ( Site 0113)

    Beverly Hills, California · Recruiting

  • Headlands Research CTR Lincoln ( Site 0127)

    Lincoln, California · Recruiting

  • Chase Medical Research, LLC ( Site 0163)

    Waterbury, Connecticut · Recruiting

  • Soffer Health Institute ( Site 0123)

    Hollywood, Florida · Recruiting

  • Westside Center for Clinical Research ( Site 0161)

    Jacksonville, Florida · Recruiting

  • Inpatient Research Clinic ( Site 0110)

    Miami Lakes, Florida · Recruiting

  • Clinical Research Trials of Florida ( Site 0101)

    Tampa, Florida · Recruiting

  • Conquest Research LLC ( Site 0140)

    Winter Park, Florida · Recruiting

  • Flourish Research - Bowie ( Site 0106)

    Bowie, Maryland · Recruiting

  • Velocity Clinical Research Rockville ( Site 0146)

    Rockville, Maryland · Recruiting

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0132)

    Troy, Michigan · Recruiting

  • Minneapolis Heart Institute - Minneapolis ( Site 0130)

    Minneapolis, Minnesota · Recruiting

  • Montana Medical Research, Inc. ( Site 0156)

    Missoula, Montana · Recruiting

  • New Mexico Clinical Research & Osteoporosis Center ( Site 0119)

    Albuquerque, New Mexico · Recruiting

  • Laurelton Heart Specialist PC ( Site 0155)

    Rosedale, New York · Recruiting

  • Velocity Clinical Research, Durham ( Site 0145)

    Durham, North Carolina · Recruiting

  • Remington-Davis, Inc. ( Site 0107)

    Columbus, Ohio · Recruiting

  • Holston Medical Group ( Site 0117)

    Kingsport, Tennessee · Recruiting

  • Center for Cardiometabolic Disease Prevention/Baylor College of Medicine ( Site 0154)

    Houston, Texas · Recruiting

  • DM Clinical Research ( Site 0115)

    Tomball, Texas · Recruiting

  • Carient Heart & Vascular - Manassas ( Site 0165)

    Manassas, Virginia · Recruiting

  • Rainier Clinical Research Center ( Site 0116)

    Renton, Washington · Recruiting

  • North York Diagnostic and Cardiac Centre ( Site 0203)

    North York, Ontario, Canada · Recruiting

  • Ecogene-21 ( Site 0202)

    Chicoutimi, Quebec, Canada · Recruiting

  • Clinique des Maladies Lipidiques de Quebec ( Site 0201)

    Québec, Quebec, Canada · Recruiting

  • Diex Recherche Trois-Rivieres ( Site 0204)

    Trois-Rivières, Quebec, Canada · Recruiting

  • Salud SURA Industriales ( Site 0405)

    Medellín, Antioquia, Colombia · Recruiting

  • Clinica de la Costa S.A.S ( Site 0404)

    Barranquilla, Atlántico, Colombia · Recruiting

  • Solano & Terront Servicios Medicos - UNIENDO SAS ( Site 0402)

    Bogota, Cundinamarca, Colombia · Recruiting

  • IMAT S.A.S ( Site 0400)

    Montería, Departamento de Córdoba, Colombia · Recruiting

  • Regionshospitalet Viborg ( Site 0507)

    Viborg, Central Jutland, Denmark · Recruiting

  • Sanos Clinic - Nordjylland ( Site 0502)

    Gandrup, North Denmark, Denmark · Recruiting

  • Esbjerg sygehus, Syddansk Universitetshospital ( Site 0505)

    Esbjerg, Region Syddanmark, Denmark · Recruiting

  • OUH Svendborg Sygehus ( Site 0500)

    Svendborg, Region Syddanmark, Denmark · Recruiting

  • zibp GmbH ( Site 0716)

    Berlin, Germany · Recruiting

  • FutureMeds GmbH ( Site 0718)

    Berlin, Germany · Recruiting

  • Charite Universitätsmedizin Berlin Campus Benjamin Franklin ( Site 0714)

    Berlin, Germany · Recruiting

  • Klinikum Konstanz ( Site 0723)

    Konstanz, Baden-Wurttemberg, Germany · Recruiting

Showing 40 of 77 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.